In vivo curcumin administration interfered with the development of distinctive characteristics associated with the NAFLD/nonalcoholic steatohepatitis phenotype, such as obesity and glucose intolerance, and improved histological alterations, including fibrosis and the intrahepatic accumulation of CD4+ cells. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatohepatitis.